Steve Cohen: portfolio of Point72 Asset Management
Steve Cohen leads Point72, the successor to SAC Capital; the portfolio holds a very large number of positions and changes often.
Source: 13F filing with the US Securities and Exchange Commission dated Feb 17, 2026. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included. Form 13F filingInvestment managers with discretion over at least 100 million USD in reportable US securities (mainly stocks and ETFs, plus options and convertible bonds) report their holdings to the SEC within 45 days after each quarter. Short positions, securities traded only abroad and cash are not included.Example: Positions as of 30 Sep, filed on 14 Nov → they are already six weeks old when published.More in the Academy: Glossary
You are looking at Q4 2025. Go to the latest filing (Q3 2026)
- Total value of stock positions
- 61.1B USD
- Positions
- 2,030
- Share of the ten largest
- 16.6%
The ten largest positions Q4 2025
- Nvidia 3.0%▲ +37.9%
- Taiwan Semiconductor Manufacturing (ADR) 2.3%▲ +157.1%
- Amazon 2.0%▲ +68.2%
- Microsoft 1.6%▼ −19.6%
- Arista Networks 1.6%▲ +37.2%
- Broadcom 1.6%▲ +80.0%
- Credo Technology Group 1.3%▲ +17.5%
- ASML Holding (ADR) 1.0%▲ +33.0%
- Sea Limited (ADR) 1.0%▲ +194.7%
- Coherent Corp. 1.0%▼ −14.4%
Show all positions of this quarter
Choose a quarter (50 filings)
- Q3 2026
- Q2 2026
- Q1 2026
- Q4 2025
- Q3 2025
- Q2 2025
- Q1 2025
- Q4 2024
- Q3 2024
- Q2 2024
- Q1 2024
- Q4 2023
- Q3 2023
- Q2 2023
- Q1 2023
- Q4 2022
- Q3 2022
- Q2 2022
- Q1 2022
- Q4 2021
- Q3 2021
- Q2 2021
- Q1 2021
- Q4 2020
- Q3 2020
- Q2 2020
- Q1 2020
- Q4 2019
- Q3 2019
- Q2 2019
- Q1 2019
- Q4 2018
- Q3 2018
- Q2 2018
- Q1 2018
- Q4 2017
- Q3 2017
- Q2 2017
- Q1 2017
- Q4 2016
- Q3 2016
- Q2 2016
- Q1 2016
- Q4 2015
- Q3 2015
- Q2 2015
- Q1 2015
- Q4 2014
- Q3 2014
- Q2 2014
All positions Q4 2025
| Symbol | Weight | Shares | Reported value | Change | Held since |
|---|---|---|---|---|---|
| DD DuPont | < 0.1% | 1,074,606 | 43.2M USD | −36.5% reduced | Q2 2019 27 quarters |
| Bicycle Therapeutics PLC | < 0.1% | 76,779 | 543.6K USD | −82.2% reduced | Q4 2019 25 quarters |
| GM General Motors | < 0.1% | 166,503 | 13.5M USD | −68.9% reduced | Q2 2020 23 quarters |
| Uniqure NV | < 0.1% | 24,439 | 584.8K USD | −90.4% reduced | Q2 2020 23 quarters |
| Post HLDGS Inc | < 0.1% | 82,655 | 8.2M USD | −71.7% reduced | Q4 2020 21 quarters |
| Dyne Therapeutics Inc | < 0.1% | 329,345 | 6.4M USD | −80.8% reduced | Q1 2021 20 quarters |
| Bath & Body Works Inc | < 0.1% | 1,873,211 | 37.6M USD | −9.7% reduced | Q3 2021 18 quarters |
| Stoneco Ltd | 0.2% | 6,325,122 | 93.5M USD | −16.5% reduced | Q4 2021 17 quarters |
| Hertz Global HLDGS Inc | < 0.1% | 1,113,413 | 5.7M USD | −44.1% reduced | Q4 2021 17 quarters |
| Pagseguro Digital Ltd | < 0.1% | 5,911,693 | 57.0M USD | −41.3% reduced | Q1 2022 16 quarters |
| Webster Finl Corp | < 0.1% | 647,058 | 40.7M USD | −20.7% reduced | Q1 2022 16 quarters |
| Axsome Therapeutics Inc | < 0.1% | 17,999 | 3.3M USD | −3.8% reduced | Q2 2022 15 quarters |
| Celldex Therapeutics Inc New | < 0.1% | 1,758,357 | 47.8M USD | −54.8% reduced | Q3 2022 14 quarters |
| ISRG Intuitive Surgical | 0.5% | 582,819 | 330.1M USD | −4.9% reduced | Q4 2022 13 quarters |
| KDP Keurig Dr Pepper | 0.3% | 6,341,111 | 177.6M USD | −10.4% reduced | Q4 2022 13 quarters |
| AMT American Tower | < 0.1% | 77,849 | 13.7M USD | −87.4% reduced | Q4 2022 13 quarters |
| Burlington Stores Inc | < 0.1% | 176,820 | 51.1M USD | −26.6% reduced | Q1 2023 12 quarters |
| Cnh Indl N V | < 0.1% | 3,332,191 | 30.7M USD | −24.3% reduced | Q1 2023 12 quarters |
| Cogent Biosciences Inc | < 0.1% | 827,525 | 29.4M USD | −33.1% reduced | Q1 2023 12 quarters |
| Topbuild Corp | < 0.1% | 40,149 | 16.7M USD | −15.3% reduced | Q1 2023 12 quarters |
| WAB Wabtec | < 0.1% | 45,956 | 9.8M USD | −88.9% reduced | Q1 2023 12 quarters |
| RAPID7 Inc | < 0.1% | 443,655 | 6.7M USD | −5.3% reduced | Q1 2023 12 quarters |
| Maxlinear Inc | < 0.1% | 78,359 | 1.4M USD | −84.4% reduced | Q1 2023 12 quarters |
| COHR Coherent Corp. | 1.0% | 3,338,935 | 616.3M USD | −14.4% reduced | Q2 2023 11 quarters |
| Arcus Biosciences Inc | 0.1% | 3,280,000 | 78.2M USD | −24.3% reduced | Q2 2023 11 quarters |
| VTR Ventas | < 0.1% | 176,334 | 13.6M USD | −32.7% reduced | Q2 2023 11 quarters |
| Foghorn Therapeutics Inc | < 0.1% | 61,968 | 334.6K USD | −83.3% reduced | Q2 2023 11 quarters |
| JD JD.com (ADR) | < 0.1% | 1,268,925 | 36.4M USD | −76.0% reduced | Q3 2023 10 quarters |
| Natera Inc | < 0.1% | 125,312 | 28.7M USD | −47.6% reduced | Q3 2023 10 quarters |
| CRH CRH plc | < 0.1% | 180,376 | 22.5M USD | −46.5% reduced | Q3 2023 10 quarters |
| MOS Mosaic Company (The) | < 0.1% | 666,965 | 16.1M USD | −41.2% reduced | Q3 2023 10 quarters |
| Parsons Corp Del | < 0.1% | 255,198 | 15.8M USD | −14.8% reduced | Q3 2023 10 quarters |
| Methanex Corp | < 0.1% | 290,812 | 11.6M USD | 0.0% reduced | Q3 2023 10 quarters |
| Abivax SA | 0.5% | 2,409,154 | 324.9M USD | −17.6% reduced | Q4 2023 9 quarters |
| Tower Semiconductor Ltd | 0.3% | 1,613,540 | 189.5M USD | −42.9% reduced | Q4 2023 9 quarters |
| Repligen Corp | 0.3% | 1,006,310 | 164.9M USD | −30.2% reduced | Q4 2023 9 quarters |
| Praxis Precision Medicines I | 0.2% | 492,346 | 145.1M USD | −67.1% reduced | Q4 2023 9 quarters |
| Ishares TR | 0.2% | 1,878,500 | 99.3M USD | −22.8% reduced | Q4 2023 9 quarters |
| Teladoc Health Inc | < 0.1% | 5,661,322 | 39.6M USD | −1.8% reduced | Q4 2023 9 quarters |
| ROST Ross Stores | 0.3% | 1,001,565 | 180.4M USD | −0.6% reduced | Q1 2024 8 quarters |
| SPDR Series Trust | 0.2% | 3,480,000 | 117.7M USD | −14.1% reduced | Q1 2024 8 quarters |
| Macom Tech Solutions HLDGS I | 0.2% | 551,641 | 94.5M USD | −4.1% reduced | Q1 2024 8 quarters |
| ZBRA Zebra Technologies | 0.1% | 302,353 | 73.4M USD | −48.0% reduced | Q1 2024 8 quarters |
| Dianthus Therapeutics Inc | < 0.1% | 1,166,088 | 48.1M USD | −42.9% reduced | Q1 2024 8 quarters |
| SHIFT4 Pmts Inc | < 0.1% | 740,956 | 46.7M USD | −51.5% reduced | Q1 2024 8 quarters |
| Icon PLC | < 0.1% | 194,150 | 35.4M USD | −58.0% reduced | Q1 2024 8 quarters |
| Jbt Marel Corporation | < 0.1% | 217,202 | 32.7M USD | −47.9% reduced | Q1 2024 8 quarters |
| Wesco Intl Inc | < 0.1% | 106,910 | 26.2M USD | −29.1% reduced | Q1 2024 8 quarters |
| Cg Oncology Inc | < 0.1% | 151,363 | 6.3M USD | −90.1% reduced | Q1 2024 8 quarters |
| Engene Holdings Inc | < 0.1% | 561,797 | 5.1M USD | −53.5% reduced | Q1 2024 8 quarters |
“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.
Show more (up to 500) Shown: the 50 longest-held of 327 positions.
Plus 1745 option positions, value of the underlying shares as reported 25.6B USD – not included in the weights.
The filing states the value of the shares the options refer to. Whether a put is a hedge or a bet on falling prices is not stated in the filing.
- SPDR S&P 500 ETF TR Put 1.7B USD
- Invesco QQQ TR Put 1.3B USD
- SPDR S&P 500 ETF TR Call 1.2B USD
- SPDR Series Trust Put 498.5M USD
- Ishares TR Put 431.5M USD
- SPDR Gold TR Put 252.0M USD
- Johnson & Johnson Put 185.8M USD
- Biogen Call 176.3M USD
- Invesco QQQ TR Call 169.1M USD
- Strategy (MicroStrategy) Call 163.1M USD
Plus 87 positions in convertible bonds and bonds worth 2.7B USD as reported – not included in the weights.
Convertible bonds and bonds, principal amount as reported. They are not stock positions and therefore do not count towards the weights.
- Wec Energy Group Inc principal 136.3M USD 154.0M USD
- Centerpoint Energy Inc principal 126.6M USD 138.5M USD
- Post HLDGS Inc principal 126.8M USD 136.7M USD
- Evergy Inc principal 100.0M USD 121.7M USD
- Ford Mtr Co principal 101.5M USD 105.3M USD
- Ugi Corp New principal 72.1M USD 102.4M USD
- Strategy Inc principal 70.0M USD 88.8M USD
- Applied Digital Corp principal 30.3M USD 82.0M USD
- Alliant Energy Corp principal 77.5M USD 80.6M USD
- The Realreal Inc principal 46.2M USD 78.5M USD
Breakdown by sector
- Technology 21.0%
- Health Care 5.5%
- Financials 5.2%
- Consumer Discretionary 5.2%
- Industrials 4.2%
- Utilities 2.6%
- Consumer Staples 2.2%
- Communication Services 2.0%
- Energy 1.5%
- Real Estate 1.4%
- Materials 1.0%
- not in our coverage 48.1%
Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.
How to read this page
- Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
- Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
- Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.
All superinvestor portfolios Screener: stocks held by superinvestors